Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

4D Molecular Therapeutics (FDMT) Asset Utilization Ratio (2021 - 2025)

4D Molecular Therapeutics (FDMT) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.17 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 270576.98% to 0.17 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.17 through Dec 2025, up 270576.98% year-over-year, with the annual reading at 0.15 for FY2025, 183849.42% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.17 at 4D Molecular Therapeutics, up from 0.0 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.17 in Q4 2025, with the low at 0.0 in Q3 2024.
  • Average Asset Utilization Ratio over 5 years is 0.04, with a median of 0.02 recorded in 2022.
  • The sharpest move saw Asset Utilization Ratio plummeted 99.95% in 2024, then soared 270576.98% in 2025.
  • Over 5 years, Asset Utilization Ratio stood at 0.06 in 2021, then plummeted by 80.99% to 0.01 in 2022, then surged by 411.85% to 0.06 in 2023, then crashed by 99.89% to 0.0 in 2024, then skyrocketed by 270576.98% to 0.17 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.17, 0.0, and 0.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.